Keyphrases
Combinatorial Strategies
100%
Ovarian Cancer
100%
IL-24
100%
Anti-angiogenesis
100%
Virotherapy
100%
Conditionally Replicating Adenovirus
100%
Antiangiogenesis Treatment
100%
ING4
100%
Virus
23%
Ovarian Cancer Cells
15%
Therapeutic Gene
15%
Cytotoxic Effect
15%
Tumor Cells
7%
Clinical Application
7%
Synergistic Effect
7%
Viral
7%
Cancer Model
7%
Therapeutic Efficacy
7%
Human Trials
7%
Neoplastic Disease
7%
Adenovirus Vector
7%
Infectious Particles
7%
Tumor Protein p53 (TP53)
7%
Selective Replication
7%
Tumoricidal Activity
7%
IL-10 Family
7%
CRAd
7%
Oncolysis
7%
Therapeutic Benefits
7%
Oncolytic Virus
7%
Oncolytic Potency
7%
Conserved Regions
7%
Cytolysis
7%
Increased Yield
7%
Yield Effect
7%
Avastin
7%
Immunomodulatory Genes
7%
Anti-VEGF Monoclonal Antibody
7%
Medicine and Dentistry
Ovarian Cancer
100%
Virotherapy
100%
Conditionally Replicating Adenovirus
100%
Antiangiogenic Therapy
100%
Virus
23%
In Vitro
15%
Cytotoxicity
15%
N (4 Methoxyphenylacetyl)dehydroalanine
15%
Cytokine
7%
Base
7%
Neoplasm
7%
Infection
7%
Cancer Cell
7%
Tumor Cell
7%
Combination Therapy
7%
Monoclonal Antibody
7%
Ovarian Cancer Cell Line
7%
Vasculotropin
7%
Interleukin 10
7%
P16
7%
Bevacizumab
7%
Oncolytic Virus
7%
Cancer Model
7%
Cytolysis
7%
Virotherapy Agent
7%
Interleukin 24
7%
Tumor Suppressor Protein
7%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Virotherapy
100%
Conditionally Replicating Adenovirus
100%
Neoplasm
15%
N (4 Methoxyphenylacetyl)dehydroalanine
15%
Cytotoxicity
15%
Infection
7%
Combination Therapy
7%
Cytokine
7%
Base
7%
Cancer Model
7%
Interleukin 24
7%
Monoclonal Antibody
7%
Vasculotropin
7%
Preclinical Study
7%
Interleukin 10
7%
Bevacizumab
7%
Oncolytic Virus
7%
Tumor Suppressor Protein
7%
Virotherapy Agent
7%
Immunology and Microbiology
Virotherapy
100%
Conditionally Replicating Adenovirus
100%
Antiangiogenic Activity
100%
Virus
23%
Cytotoxicity
15%
Cytokine
7%
Tumor Cell
7%
Monoclonal Antibody
7%
Interleukin 24
7%
Cancer Cell
7%
Interleukin 10
7%
Preclinical Study
7%
Vasculotropin
7%
Ovarian Cancer Cell Line
7%
Bevacizumab
7%
Oncolytic Virus
7%
Cytolysis
7%
Virotherapy Agent
7%